490
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

The association between inflammatory biomarkers and low back disorder: a systematic review and meta-analysis

ORCID Icon, ORCID Icon & ORCID Icon
Pages 171-184 | Received 08 May 2023, Accepted 01 Apr 2024, Published online: 11 Apr 2024

References

  • Al-Rawaf HA, Gabr SA, Alghadir AH. 2021. Vitamin D deficiency and molecular changes in circulating microRNAs in older adults with lower back pain. Pain Res Manag. 2021:6662651–13. doi: 10.1155/2021/6662651
  • Andrade P, Hoogland G, Garcia MA, Steinbusch HW, Daemen MA, Visser-Vandewalle V. 2013. Elevated IL-1β and IL-6 levels in lumbar herniated discs in patients with sciatic pain. Eur Spine J. 22(4):714–720. doi: 10.1007/s00586-012-2502-x
  • Ansar W, Ghosh S, Ansar W, Ghosh S. 2016. Inflammation and inflammatory diseases, markers, and mediators: role of CRP in some inflammatory diseases. Biol C React Protein Health Dis. 24:67–107.
  • Baumeister D, Akhtar R, Ciufolini S, Pariante CM, Mondelli V. 2016. Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α. Mol Psychiatry. 21(5):642–649. doi: 10.1038/mp.2015.67
  • Biczo A, Bereczki F, Koch K, Varga PP, Lazary A, Genodisc Consortium. 2022. Genetic variants of interleukin 1B and 6 are associated with clinical outcome of surgically treated lumbar degenerative disc disease. BMC Musculoskelet Disord. 23(1):774. doi: 10.1186/s12891-022-05711-0
  • Bobechko W, Hirsch C. 1965. Auto-immune response to nucleus pulposus in the rabbit. J Bone Joint Surg Br. 47:574–580.
  • Brandt C, Pedersen BK. 2010. The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases. J Biomed Biotechnol. 2010:520258–6. doi: 10.1155/2010/520258
  • Burke J, Watson R, Mccormack D, Dowling F, Walsh M, Fitzpatrick J. 2002. Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br. 84(2):196–201. doi: 10.1302/0301-620x.84b2.12511
  • Capossela S, Pavlicek D, Bertolo A, Landmann G, Stoyanov JV. 2018. Unexpectedly decreased plasma cytokines in patients with chronic back pain. J Pain Res. 11:1191–1198. doi: 10.2147/JPR.S153872
  • Cheng L, Fan W, Liu B, Wang X, Nie L. 2013. Th17 lymphocyte levels are higher in patients with ruptured than non-ruptured lumbar discs, and are correlated with pain intensity. Injury. 44(12):1805–1810. doi: 10.1016/j.injury.2013.04.010
  • Chou R. 2014. In the clinic. Low back pain. Ann Intern Med. 160(11):ITC6–ITC1. doi: 10.7326/0003-4819-160-11-201406030-01006
  • Christgau S. 2000. Circadian variation in serum CrossLaps concentration is reduced in fasting individuals. Clin Chem. 46(3):431–431.
  • Cuellar JM, Golish SR, Reuter MW, Cuellar VG, Angst MS, Carragee EJ, Yeomans DC, Scuderi GJ. 2010. Cytokine evaluation in individuals with low back pain using discographic lavage. Spine J. 10(3):212–218. doi: 10.1016/j.spinee.2009.12.007
  • Degenhardt BF, Johnson JC, Fossum C, Andicochea CT, Stuart MK. 2017. Changes in cytokines, sensory tests, and self-reported pain levels after manual treatment of low back pain. Clin Spine Surg. 30(6):E690–E701. doi: 10.1097/BSD.0000000000000231
  • Deshmane SL, Kremlev S, Amini S, Sawaya BE. 2009. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 29(6):313–326. doi: 10.1089/jir.2008.0027
  • Dhahri R, Dghaies A, Slouma M, Metoui L, Gharsallah I, Dorgham I, Ayari R, Mallat Y, Amri K, Tezeghdenti A. 2021. POS1290 cytokine biomarkers in common low back pain. Ann Rheum Dis. 80:926.
  • Du Clos TW. 2000. Function of C-reactive protein. Ann Med. 32(4):274–278. doi: 10.3109/07853890009011772
  • Ehrlich GE. 2003. Back pain. J Rheumatol Suppl. 67:26–31.
  • Elkan P, Sten-Linder M, Hedlund R, Willers U, Ponzer S, Gerdhem P. 2016. Markers of inflammation and fibrinolysis in relation to outcome after surgery for lumbar disc herniation. A prospective study on 177 patients. Eur Spine J. 25(1):186–191. doi: 10.1007/s00586-015-3998-7
  • France RD, Urban BJ. 1991. Cerebrospinal fluid concentrations of beta-endorphin in chronic low back pain patients: influence of depression and treatment. Psychosomatics. 32(1):72–77. doi: 10.1016/S0033-3182(91)72114-2
  • Gebhardt K, Brenner H, Stürmer T, Raum E, Richter W, Schiltenwolf M, Buchner M. 2006. The course of high-sensitive C-reactive protein in correlation with pain and clinical function in patients with acute lumbosciatic pain and chronic low back pain–a 6 months prospective longitudinal study. Eur J Pain. 10(8):711–719. doi: 10.1016/j.ejpain.2005.11.005
  • Gjefsen E, Gervin K, Goll G, Bråten LCH, Wigemyr M, Aass HCD, Vigeland MD, Schistad E, Pedersen LM, Pripp AH, et al. 2021. Macrophage migration inhibitory factor: a potential biomarker for chronic low back pain in patients with Modic changes. RMD Open. 7(2):e001726. doi: 10.1136/rmdopen-2021-001726
  • Grandidge L, Athanassacopolous M, Breakwell L, Chiverton N, Ivanov M, Michael R, Zaki H, Cole A. 2015. Oswestry disability index (ODI) and visual analogue score (VAS) in pre-operative patients with radicular leg pain. Spine J. 15(3):S53–S54. doi: 10.1016/j.spinee.2014.12.037
  • Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, et al. 2011. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 64(4):383–394., doi: 10.1016/j.jclinepi.2010.04.026
  • Habtemariam A, Grönblad M, Virri J, Seitsalo S, Karaharju E. 1998. A comparative immunohistochemical study of inflammatory cells in acute-stage and chronic-stage disc herniations. Spine (Phila Pa 1976). 23(20):2159–2165; discussion 2166. doi: 10.1097/00007632-199810150-00003
  • Hagen K, Stovner LJ, Nilsen KB, Kristoffersen ES, Winsvold BS. 2019. The impact of C-reactive protein levels on headache frequency in the HUNT study 2006–2008. BMC Neurol. 19(1):229. doi: 10.1186/s12883-019-1462-8
  • Hider SL, Konstantinou K, Hay EM, Glossop J, Mattey DL. 2019. Inflammatory biomarkers do not distinguish between patients with sciatica and referred leg pain within a primary care population: results from a nested study within the ATLAS cohort. BMC Musculoskelet Disord. 20(1):202. doi: 10.1186/s12891-019-2604-2
  • Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC, Cochrane Statistical Methods Group. 2011. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 343(2):d5928–d5928. doi: 10.1136/bmj.d5928
  • Hodges S, Guler S, Sacca V, Vangel M, Orr S, Pace-Schott E, Wen Y, Ge T, Kong J. 2023. Associations among acute and chronic musculoskeletal pain, sleep duration, and C-reactive protein (CRP): a cross-sectional study of the UK biobank dataset. Sleep Med. 101:393–400. doi: 10.1016/j.sleep.2022.11.013
  • Holmberg MJ, Andersen LW. 2022. Collider bias. JAMA. 327(13):1282–1283. doi: 10.1001/jama.2022.1820
  • Hoozemans MJ, Koppes LL, Twisk JW, Van Dieën JH. 2012. Lumbar bone mass predicts low back pain in males. Spine (Phila Pa 1976). 37(18):1579–1585. doi: 10.1097/BRS.0b013e31825409d8
  • Jimbo K, Park JS, Yokosuka K, Sato K, Nagata K. 2005. Positive feedback loop of interleukin-1β upregulating production of inflammatory mediators in human intervertebral disc cells in vitro. J Neurosurg Spine. 2(5):589–595. doi: 10.3171/spi.2005.2.5.0589
  • Klyne DM, Barbe MF, Van Den Hoorn W, Hodges PW. 2018. ISSLS Prize in clinical science 2018: longitudinal analysis of inflammatory, psychological, and sleep-related factors following an acute low back pain episode—the good, the bad, and the ugly. Eur Spine J. 27(4):763–777. doi: 10.1007/s00586-018-5490-7
  • Koivisto K, Karppinen J, Haapea M, Järvinen J, Kyllönen E, Tervonen O, Niinimäki J, Alini M, Lotz J, Dudli S, et al. 2019. The effect of zoledronic acid on serum biomarkers among patients with chronic low back pain and modic changes in lumbar magnetic resonance imaging. Diagnostics. 9(4):212. doi: 10.3390/diagnostics9040212
  • Kraychete DC, Sakata RK, Issy AM, Bacellar O, Santos-Jesus R, Carvalho EM. 2010. Serum cytokine levels in patients with chronic low back pain due to herniated disc: analytical cross-sectional study. Sao Paulo Med J. 128(5):259–262. doi: 10.1590/s1516-31802010000500003
  • Krock E, Millecamps M, Anderson KM, Srivastava A, Reihsen TE, Hari P, Sun YR, Jang SH, Wilcox GL, Belani KG, et al. 2019. Interleukin-8 as a therapeutic target for chronic low back pain: upregulation in human cerebrospinal fluid and pre-clinical validation with chronic reparixin in the SPARC-null mouse model. EBioMedicine. 43:487–500. doi: 10.1016/j.ebiom.2019.04.032
  • Lee S, Nam CM, Yoon DH, Kim KN, Yi S, Shin DA, Ha Y. 2013. Association between low-back pain and lumbar spine bone density: a population-based cross-sectional study. J Neurosurg Spine. 19(3):307–313. doi: 10.3171/2013.5.SPINE12473
  • Li Y, Liu J, Liu Z-Z, Duan D-P. 2016. Inflammation in low back pain may be detected from the peripheral blood: suggestions for biomarker. Biosci Rep. 36(4):e00361. doi: 10.1042/BSR20160187
  • Lin W-C, Yeh CH, Chien L-C, Morone NE, Glick RM, Albers KM. 2015. The anti-inflammatory actions of auricular point acupressure for chronic low back pain. Evid Based Complement Alternat Med. 2015:1–9. doi: 10.1155/2015/103570
  • Luchting B, Heyn J, Woehrle T, Rachinger-Adam B, Kreth S, Hinske LC, Azad SC. 2016. Differential expression of P2X7 receptor and IL-1β in nociceptive and neuropathic pain. J Neuroinflammation. 13(1):100. doi: 10.1186/s12974-016-0565-z
  • Marx RE, Cillo JE, Jr, Ulloa JJ. 2007. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 65(12):2397–2410. doi: 10.1016/j.joms.2007.08.003
  • Modi WS, Dean M, Seuanez HN, Mukaida N, Matsushima K, O’brien SJ. 1990. Monocyte-derived neutrophil chemotactic factor (MDNCF/IL-8) resides in a gene cluster along with several other members of the platelet factor 4 gene superfamily. Hum Genet. 84(2):185–187. doi: 10.1007/BF00208938
  • O’donnell JL, O’donnell AL. 1996. Prostaglandin E2 content in herniated lumbar disc disease. Spine (Phila Pa 1976). 21(14):1653–1655. doi: 10.1097/00007632-199607150-00007
  • O’garra A, Barrat FJ, Castro AG, Vicari A, Hawrylowicz C. 2008. Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev. 223(1):114–131. doi: 10.1111/j.1600-065X.2008.00635.x
  • Ohtori S, Suzuki M, Koshi T, Takaso M, Yamashita M, Inoue G, Yamauchi K, Orita S, Eguchi Y, Kuniyoshi K, et al. 2011. Proinflammatory cytokines in the cerebrospinal fluid of patients with lumbar radiculopathy. Eur Spine J. 20(6):942–946. doi: 10.1007/s00586-010-1595-3
  • Park CH, Lee SH. 2011. Prognostic usefulness of high sensitivity C-reactive protein for transforaminal epidural steroid injection in patients with radicular pain. Pain Med. 12(2):219–223. doi: 10.1111/j.1526-4637.2010.01039.x
  • Pedersen LM, Schistad E, Jacobsen LM, Røe C, Gjerstad J. 2015. Serum levels of the pro-inflammatory interleukins 6 (IL-6) and-8 (IL-8) in patients with lumbar radicular pain due to disc herniation: a 12-month prospective study. Brain Behav Immun. 46:132–136. doi: 10.1016/j.bbi.2015.01.008
  • Queiroz BZ, Pereira DS, De Britto Rosa NM, Lopes RA, Andrade AGP, Felício DC, Jardim RMFVS, Leopoldino AaO, Silva JP, Pereira LSM. 2017. Inflammatory mediators and pain in the first year after acute episode of low-back pain in elderly women: longitudinal data from back complaints in the elders—Brazil. Am J Phys Med Rehabil. 96(8):535–540. doi: 10.1097/PHM.0000000000000661
  • Queiroz BZ, Pereira DS, Rosa N. M d B, Lopes RA, Felício DC, Pereira DG, Dias JMD, Dias RC, Pereira LSM. 2015. Functional performance and plasma cytokine levels in elderly women with and without low back pain. J Back Musculoskelet Rehabil. 28(2):343–349. doi: 10.3233/BMR-140526
  • Rannou F, Ouanes W, Boutron I, Lovisi B, Fayad F, Macé Y, Borderie D, Guerini H, Poiraudeau S, Revel M. 2007. High-sensitivity C-reactive protein in chronic low back pain with vertebral end-plate Modic signal changes. Arthritis Rheum. 57(7):1311–1315. doi: 10.1002/art.22985
  • Rathod TN, Chandanwale A, Ladkat KM, Chavan S, Chavan A, Bhosale PB. 2014. High sensitive C-reactive protein-effective tool in determining postoperative recovery in lumbar disc disease. Indian J Orthop. 48(4):354–359. doi: 10.4103/0019-5413.136216
  • Ren K, Dubner R. 2010. Interactions between the immune and nervous systems in pain. Nat Med. 16(11):1267–1276. doi: 10.1038/nm.2234
  • Risbud MV, Shapiro IM. 2014. Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol. 10(1):44–56. doi: 10.1038/nrrheum.2013.160
  • Sainoh T, Orita S, Miyagi M, Suzuki-Narita M, Sakuma Y, Oikawa Y, Kubota G, Sato J, Shiga Y, Fujimoto K, et al. 2022. Improvements in intractable lumbar and lower-extremity symptoms after systemic administration of tocilizumab, an anti-interleukin-6 receptor antibody. Asian Spine J. 16(1):99–106. doi: 10.31616/asj.2020.0283
  • Skelly AC, Dettori JR, Brodt ED. 2012. Assessing bias: the importance of considering confounding. Evid Based Spine Care J. 3(1):9–12. doi: 10.1055/s-0031-1298595
  • Snider KT, Johnson JC, Degenhardt BF, Snider EJ. 2011. Low back pain, somatic dysfunction, and segmental bone mineral density T-score variation in the lumbar spine. J Osteopathic Med. 111:89–96.
  • Surbakti KP, Nasution I. 2020. Association between serum levels of high sensitivity C-reactive protein, interleukin-1 and interleukin-6 with pain intensity in patients with low back pain without sciatica. Open Access Maced J Med Sci. 8(B):6–10. doi: 10.3889/oamjms.2020.4114
  • Takahashi H, Suguro T, Okazima Y, Motegi M, Okada Y, Kakiuchi T. 1996. Inflammatory cytokines in the herniated disc of the lumbar spine. Spine (Phila Pa 1976). 21(2):218–224. doi: 10.1097/00007632-199601150-00011
  • Tang Y, Liang P, Chen J, Fu S, Liu B, Feng M, Lin B, Lee B, Xu A, Lan HY. 2018. The baseline levels and risk factors for high-sensitive C-reactive protein in Chinese healthy population. Immun Ageing. 15(1):1–8. doi: 10.1186/s12979-018-0126-7
  • Teodorczyk-Injeyan JA, Mcgregor M, Triano JJ, Injeyan SH. 2018. Elevated production of nociceptive CC chemokines and sE-selectin in patients with low back pain and the effects of spinal manipulation: a nonrandomized clinical trial. Clin J Pain. 34(1):68–75. doi: 10.1097/AJP.0000000000000507
  • Uçeyler N, Valenza R, Stock M, Schedel R, Sprotte G, Sommer C. 2006. Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum. 54(8):2656–2664. doi: 10.1002/art.22026
  • Wang K, Bao J-P, Yang S, Hong X, Liu L, Xie X-H, Wu X-T. 2016. A cohort study comparing the serum levels of pro-or anti-inflammatory cytokines in patients with lumbar radicular pain and healthy subjects. Eur Spine J. 25(5):1428–1434. doi: 10.1007/s00586-015-4349-4
  • Weber K, Satoh S, Alipui DO, Virojanapa J, Levine M, Sison C, Quraishi S, Bloom O, Chahine NO. 2015. Exploratory study for identifying systemic biomarkers that correlate with pain response in patients with intervertebral disc disorders. Immunol Res. 63(1-3):170–180. doi: 10.1007/s12026-015-8709-2
  • Wells GA, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P. 2000. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. University of Ottawa. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
  • Wynne-Jones G, Cowen J, Jordan JL, Uthman O, Main CJ, Glozier N, Van Der Windt D. 2014. Absence from work and return to work in people with back pain: a systematic review and meta-analysis. Occup Environ Med. 71(6):448–456. doi: 10.1136/oemed-2013-101571
  • Yang H, Liu H, Li Z, Zhang K, Wang J, Wang H, Zheng Z. 2015. Low back pain associated with lumbar disc herniation: role of moderately degenerative disc and annulus fibrous tears. Int J Clin Exp Med. 8:1634.
  • Yuen JW, Tsang WW, Sonny H, Loo WT, Chan S-T, Wong DL, Chung HH, Tam JK, Choi TK, Chiang VC. 2017. The effects of Gua sha on symptoms and inflammatory biomarkers associated with chronic low back pain: a randomized active-controlled crossover pilot study in elderly. Complement Ther Med. 32:25–32. doi: 10.1016/j.ctim.2017.03.010
  • Zetterman T, Markkula R, Kalso E. 2022. Elevated highly sensitive C-reactive protein in fibromyalgia associates with symptom severity. Rheumatol Adv Pract. 6(2):rkac053. doi: 10.1093/rap/rkac053